Astrazeneca UK Limited
Private Limited Company · Cambridge
ActiveUnited KingdomIncorporated 1998Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No electronic account filings
No extracted electronic accounts are available in our records.
Registered details
03674842- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 1998-11-26
- Jurisdiction
- —
- Registered office
- 1, FRANCIS CRICK AVENUE, CAMBRIDGE, CB2 0AA, UNITED KINGDOM
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
34 matched grantsRACR East: an East of England Consortium to support Clinical AcademicsActiveMRC · Fellowship · 2026-06-29 – 2030-06-29 · with 29 other participants£1,400,000whole project
RACR East: an East of England Consortium to support Clinical AcademicsActive
MRC · Fellowship · 2026-06-29 – 2030-06-29 · with 29 other participants
£1,400,000
whole project
University Of CambridgeleadAstrazeneca UK LimitedCambridgeshire And Peterborough NHS Foundation TrustCambridge University Health PartnersCambridge University Hospitals NHS Foundation TrustEarlham InstituteEast Suffolk And North Essex NHS Foundation TrustFlagship PioneeringJames Paget University Hospitals NHS Foundation TrustJohn Innes CentreMid And South Essex NHS Foundation TrustMilton Keynes HospitalNHS Cambridgeshire and Peterborough Integrated Care BoardNHS Mid and South Essex Integrated Care SystemNHS Norfolk & Waveny Integrated Care BoardNHS Suffolk & North East Essex Integrated Care SystemNIHR Cambridge Biomedical Research CentreNorfolk and Norwich University Hospitals NHS Foundation TrustNorfolk and Suffolk NHS Foundation TrustNorfolk and Waveney University Hospitals Group North West Anglia NHS Foundation TrustPapworth Hospital NHS Foundation TrustPrincess Alexandra Hospital NHS TrustQuadram Institute BioscienceQueen Elizabeth Hospital King's Lynn NHS Foundation TrustUEA Health and Social Care PartnersVictor Phillip Dahdaleh Heart and Lung Research InstituteWellcome Sanger InstituteWest Hertfordshire Teaching Hospitals NHS TrustWest Suffolk NHS Foundation Trust
A universal catalyst design framework for late-stage functionalisationActiveEPSRC · Research Grant · 2026-02-02 – 2029-02-02 · with 1 other participant£498,506whole project
A universal catalyst design framework for late-stage functionalisationActive
EPSRC · Research Grant · 2026-02-02 – 2029-02-02 · with 1 other participant
£498,506
whole project
University Of EdinburghleadAstrazeneca UK Limited
IMPALA-NET UK: Integral Membrane Proteins And Lipid Assemblies NETwork UKActiveBBSRC · Research Grant · 2026-01-26 – 2029-01-26 · with 8 other participants£513,286whole project
IMPALA-NET UK: Integral Membrane Proteins And Lipid Assemblies NETwork UKActive
BBSRC · Research Grant · 2026-01-26 – 2029-01-26 · with 8 other participants
£513,286
whole project
Aston UniversityleadAstrazeneca UK LimitedCoding BioDJS Antibodies (Abbvie)Domainex (United Kingdom)F2G LtdMaxion TherapeuticsMolecular Dimensions (Calibre Scientific)Peak Proteins (Sygnature Discovery)
Total Body Nuclear Imaging for the Development of NanotheranosticsActiveEPSRC · Research Grant · 2026-01-05 – 2031-01-05 · with 20 other participants£9,980,399whole project
Total Body Nuclear Imaging for the Development of NanotheranosticsActive
EPSRC · Research Grant · 2026-01-05 – 2031-01-05 · with 20 other participants
£9,980,399
whole project
King'S College LondonleadAstral SystemsAstrazeneca UK LimitedCentre for Process Innovation CPI (UK)Cyclife Aquila NuclearEVOX Therapeutics LtdGE HealthcareInnoMedica Holding AGInternational Iberian Nanotechnology LaboratoryJohnson & Johnson (United Kingdom)McMaster UniversityMediso Medical Imaging Systems LtdNanotechnology Industries AssociationNational Nuclear Laboratory (Nnl)National PET Imaging Platform (NPIP)Perceptive DiscoveryPerspective TherapeuticsPrecision X-ray IrradiationSiemens Healthcare (Germany)Stream Bio LtdVacV Biotherapeutics
MRC Centre of Research Excellence in Clinical Trial Innovation in partnership with NIHRActiveMRC · Research Grant · 2026-01-02 – 2033-01-02 · with 36 other participants£22,117,999whole project
MRC Centre of Research Excellence in Clinical Trial Innovation in partnership with NIHRActive
MRC · Research Grant · 2026-01-02 – 2033-01-02 · with 36 other participants
£22,117,999
whole project
University College LondonleadAstrazeneca UK LimitedAustralian Trials Methodology Research NetworkBoehringer Ingelheim (Germany)Cardiff UniversityCytel (United States)Derek C Stewart Associates LtdDrugs for Neglected Diseases InitiativeGskICON Clinical Research (UK) LtdImperial College LondonJohnson & JohnsonKing'S College LondonLiverpool School Of Tropical MedicineMalawi Epidemiology and Intervention Research UnitMalawi Liverpool Wellcome ProgrammeMRC Unit, The GambiaMRC/UVRI Uganda Research UnitNational Cancer GridNetherlands Cancer InstituteNovartis (Switzerland)Penta IdQueen Elizabeth Hospital BirminghamRocheRoyal College of Surgeons of EnglandSouthampton UniversitySt George'S University Of LondonStriveSwiss Clinical Trial OrganisationThe Health Research Unit, ZimbabweUCB Pharma (United Kingdom)UkcrcUK Dementia Research InstituteUniversity Of LeicesterUniversity Of NottinghamUniversity Of OxfordViiV Healthcare
ECOSOLUTIONS: Transforming Chemical Management for a Non-Toxic FutureActiveNERC · Training Grant · 2025-09-30 – 2032-04-30 · with 22 other participants£975,840whole project
ECOSOLUTIONS: Transforming Chemical Management for a Non-Toxic FutureActive
NERC · Training Grant · 2025-09-30 – 2032-04-30 · with 22 other participants
£975,840
whole project
University of SheffieldleadAstrazeneca UK LimitedBeiersdorf (Germany)Cambridge Environmental Research Consultants (United Kingdom)Conflict and Environment ObservatoryCroda (United Kingdom)DEFRA WestminsterEnvironment AgencyFera Science (United Kingdom)FidraHealth and Safety ExecutiveJNCC (Joint Nature Conserv Committee)Natural EnglandNatural Resources WalesNHS EnglandReckitt Benckiser (United Kingdom)Ricardo (United Kingdom)Royal Society For The Protection Of BirdsScottish GovernmentScymarisThe Rivers TrustUnilever (United Kingdom)Vitis Regulatory
Phosphoinositide signalling as a regulator of tumour growth and metastasisActiveUKRI FLF · Fellowship · 2025-09-30 – 2028-09-30 · with 3 other participants£593,674whole project
Phosphoinositide signalling as a regulator of tumour growth and metastasisActive
UKRI FLF · Fellowship · 2025-09-30 – 2028-09-30 · with 3 other participants
£593,674
whole project
University of GlasgowleadAstrazeneca UK LimitedCancer Research HorizonsCancer Research UK Scotland Institute
A sustainable future factoryLeadInnovate UK · Feasibility Studies · 2025-01-01 – 2025-06-30 · with 2 other participants£45,828awarded
A sustainable future factoryLead
Innovate UK · Feasibility Studies · 2025-01-01 – 2025-06-30 · with 2 other participants
£45,828
awarded
UK Open Multimodal AI Network (UKOMAIN)ActiveEPSRC · Research Grant · 2025-01-01 – 2028-01-01 · with 35 other participants£1,820,258whole project
UK Open Multimodal AI Network (UKOMAIN)Active
EPSRC · Research Grant · 2025-01-01 – 2028-01-01 · with 35 other participants
£1,820,258
whole project
University of SheffieldleadAdvanced Manufacturing Research CentreAstrazeneca UK LimitedBenevolentAI (United Kingdom)British Antarctic SurveyBrunel University LondonEarth BloxEPSRC AI Hub for Causality in Healthcare AI with Real DataHenry Royce InstituteImperial College LondonKing'S College LondonLiverpool John Moores UniversityMetaNational Health ServiceNational University of SingaporeNewcastle UniversityNovo Nordisk (United Kingdom)Offshore Renewable Energy CatapultQueen Mary University Of LondonRéseau ConsultingResponsible AI InstituteRiskThinking.ASatVuUK Acoustics NetworkUK Centre for Greening Finance & InvestmentUKRI Digital Twinning NetworkPlusUnep/GridUniversity of BristolUniversity Of CambridgeUniversity Of EdinburghUniversity Of ExeterUniversity of GlasgowUniversity Of ManchesterUniversity Of NottinghamUniversity Of OxfordUniversity of Southampton
A Regulatory Science Network for the Digital Transformation of Medicines Development and ManufacturingInnovate UK · Collaborative R&D · 2024-03-01 – 2024-08-31 · with 4 other participants£0awarded
A Regulatory Science Network for the Digital Transformation of Medicines Development and Manufacturing
Innovate UK · Collaborative R&D · 2024-03-01 – 2024-08-31 · with 4 other participants
£0
awarded
University of Strathclydelead£36,370
Astrazeneca UK Limited£0
Maximising Efficiency of Liquid Phase Oligo Synthesis (MELOS)Innovate UK · Collaborative R&D · 2023-06-01 – 2025-11-30 · with 3 other participants£0awarded
Maximising Efficiency of Liquid Phase Oligo Synthesis (MELOS)
Innovate UK · Collaborative R&D · 2023-06-01 – 2025-11-30 · with 3 other participants
£0
awarded
Astrazeneca UK Limited£0
101057668 — Eternal — Horizon-Hlth-2021-Ind-07Lead
Innovate UK · EU-Funded · 2022-09-01 – 2026-08-31
£703,796
awarded
101057668 — Eternal — Horizon-Hlth-2021-Ind-07LeadActive
Horizon Europe Guarantee · EU-Funded · 2022-08-31 – 2026-08-30
£705,676
whole project
101057668 — Eternal — Horizon-Hlth-2021-Ind-07Active
Horizon Europe Guarantee · EU-Funded · 2022-08-31 – 2026-08-30
£705,676
whole project
A coordinated strategy to scale-up advanced therapies for patient in ManchesterInnovate UK · Centres · 2021-04-01 – 2022-03-31 · with 11 other participants£0awarded
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 11 other participants
£0
awarded
Manchester University NHS Foundation Trust£270,594
The Christie NHS Foundation Trustlead£252,199
Astrazeneca UK Limited£0
Sheffield Teaching Hospitals NHS Foundation Trust£0
A coordinated strategy to scale-up advanced therapies for patient in ManchesterISCF · Centres · 2021-03-31 – 2022-03-30 · with 12 other participants£1,759,515whole project
A coordinated strategy to scale-up advanced therapies for patient in Manchester
ISCF · Centres · 2021-03-31 – 2022-03-30 · with 12 other participants
£1,759,515
whole project
The Christie NHS Foundation TrustleadAgentus Therapeutics LtdAptus Clinical LimitedAstrazeneca UK LimitedChaucer Group LimitedDatatrial LimitedFormedix LimitedGlobal Life Sciences Solutions Operations UK LtdInstil Bio (UK) LimitedManchester University NHS Foundation TrustSheffield Teaching Hospitals NHS Foundation TrustThe Christie Pathology Partnership LLPThe University Of Manchester
Accelerating the development of biotherapeutics for subcutaneous deliveryInnovate UK · Study · 2021-03-01 – 2024-02-29 · with 1 other participant£0awarded
Accelerating the development of biotherapeutics for subcutaneous delivery
Innovate UK · Study · 2021-03-01 – 2024-02-29 · with 1 other participant
£0
awarded
Astrazeneca UK Limited£0
Accelerating the development of biotherapeutics for subcutaneous deliveryUKRI Inn.Scholar · Study · 2021-03-01 – 2024-02-29 · with 1 other participant£101,552whole project
Accelerating the development of biotherapeutics for subcutaneous delivery
UKRI Inn.Scholar · Study · 2021-03-01 – 2024-02-29 · with 1 other participant
£101,552
whole project
King'S College LondonleadAstrazeneca UK Limited
Use of OrbiSIMS to identify impurities on drug crystal surfaces and characterise surface chemical structures on spray-dried pharmaceutical formulationsLeadInnovate UK · Collaborative R&D · 2020-06-01 – 2021-06-30 · with 1 other participant£10,010awarded
Use of OrbiSIMS to identify impurities on drug crystal surfaces and characterise surface chemical structures on spray-dried pharmaceutical formulationsLead
Innovate UK · Collaborative R&D · 2020-06-01 – 2021-06-30 · with 1 other participant
£10,010
awarded
Astrazeneca UK Limitedlead£10,010
Digital Design Accelerator Platform to Connect Active Material Design to Product PerformanceISCF · Collaborative R&D · 2020-03-01 – 2022-08-30 · with 9 other participants£1,748,002whole project
Digital Design Accelerator Platform to Connect Active Material Design to Product Performance
ISCF · Collaborative R&D · 2020-03-01 – 2022-08-30 · with 9 other participants
£1,748,002
whole project
Digital Design Accelerator Platform to Connect Active Material Design to Product PerformanceLeadInnovate UK · Collaborative R&D · 2020-03-01 – 2022-08-31 · with 9 other participants£0awarded
Digital Design Accelerator Platform to Connect Active Material Design to Product PerformanceLead
Innovate UK · Collaborative R&D · 2020-03-01 – 2022-08-31 · with 9 other participants
£0
awarded
University of Strathclyde£198,681
Astrazeneca UK Limitedlead£0
Digital Design Accelerator Platform to Connect Active Material Design to Product PerformanceLeadISCF · Collaborative R&D · 2020-03-01 – 2022-08-30 · with 9 other participants£1,748,002whole project
Digital Design Accelerator Platform to Connect Active Material Design to Product PerformanceLead
ISCF · Collaborative R&D · 2020-03-01 – 2022-08-30 · with 9 other participants
£1,748,002
whole project
University of Warwick and AstraZeneca UK LimitedInnovate UK · Knowledge Transfer Partnership · 2019-09-01 – 2021-08-31 · with 1 other participant
University of Warwick and AstraZeneca UK Limited
Innovate UK · Knowledge Transfer Partnership · 2019-09-01 – 2021-08-31 · with 1 other participant
Astrazeneca UK Limited—
Genomics Main Phase - Early DiagnosisLead
Innovate UK · Collaborative R&D · 2019-08-01 – 2020-03-31
£12,500,000
awarded
Genomics Main Phase - Early Diagnosis
ISCF · Collaborative R&D · 2019-07-31 – 2020-03-30
£12,500,000
whole project
Genomics Main Phase - Early DiagnosisLead
ISCF · Collaborative R&D · 2019-07-31 – 2020-03-30
£12,500,000
whole project
Combining Organ-on-Chip Models of Fatty Liver with Computational Biology to Enable Drug Re-purposingInnovate UK · Collaborative R&D · 2017-10-01 – 2019-03-31 · with 1 other participant£113,592awarded
Combining Organ-on-Chip Models of Fatty Liver with Computational Biology to Enable Drug Re-purposing
Innovate UK · Collaborative R&D · 2017-10-01 – 2019-03-31 · with 1 other participant
£113,592
awarded
Astrazeneca UK Limited£113,592
Combining Organ-on-Chip Models of Fatty Liver with Computational Biology to Enable Drug Re-purposingISCF · Collaborative R&D · 2017-09-30 – 2019-03-31 · with 1 other participant£341,988whole project
Combining Organ-on-Chip Models of Fatty Liver with Computational Biology to Enable Drug Re-purposing
ISCF · Collaborative R&D · 2017-09-30 – 2019-03-31 · with 1 other participant
£341,988
whole project
Cn Bio Innovations LimitedleadAstrazeneca UK Limited
Virtual Fish Ecotoxicology LaboratoryInnovate UK · Collaborative R&D · 2016-03-01 – 2019-02-28 · with 2 other participants£1,589awarded
Virtual Fish Ecotoxicology Laboratory
Innovate UK · Collaborative R&D · 2016-03-01 – 2019-02-28 · with 2 other participants
£1,589
awarded
University of Bradford and AstraZeneca UK LimitedInnovate UK · Knowledge Transfer Partnership · 2015-10-01 – 2017-03-31 · with 1 other participant
University of Bradford and AstraZeneca UK Limited
Innovate UK · Knowledge Transfer Partnership · 2015-10-01 – 2017-03-31 · with 1 other participant
Astrazeneca UK Limited—
Accelerating paediatric formulation development through smart design and predictive scienceLeadInnovate UK · Collaborative R&D · 2014-07-01 – 2018-03-31 · with 9 other participants£73,889awarded
Accelerating paediatric formulation development through smart design and predictive scienceLead
Innovate UK · Collaborative R&D · 2014-07-01 – 2018-03-31 · with 9 other participants
£73,889
awarded
University of Bath£92,000
Astrazeneca UK Limitedlead£73,889
Aston University£14,520
Digital Design of Drug ProductsInnovate UK · Collaborative R&D · 2014-06-01 – 2016-05-31 · with 3 other participants£31,236awarded
Digital Design of Drug Products
Innovate UK · Collaborative R&D · 2014-06-01 – 2016-05-31 · with 3 other participants
£31,236
awarded
Astrazeneca UK Limited£31,236
Formulation for targeted delivery of novel therapies for oncologyLeadInnovate UK · Collaborative R&D · 2014-05-01 – 2019-03-31 · with 2 other participants£105,272awarded
Formulation for targeted delivery of novel therapies for oncologyLead
Innovate UK · Collaborative R&D · 2014-05-01 – 2019-03-31 · with 2 other participants
£105,272
awarded
The University of York And AstraZeneca UK LimitedInnovate UK · Knowledge Transfer Partnership · 2011-04-01 – 2014-03-31 · with 1 other participant
The University of York And AstraZeneca UK Limited
Innovate UK · Knowledge Transfer Partnership · 2011-04-01 – 2014-03-31 · with 1 other participant
Astrazeneca UK Limited—